Schonfeld Strategic Advisors LLC Organogenesis Holdings Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.9 - $4.3 $32,300 - $73,100	17,000 New	17,000 $56,000
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $371,217 - $638,275	-78,316 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $506,704 - $749,484	78,316 New	78,316 $597,000
Q1 2021 May 17, 2021	SELL	$7.33 - $21.06 $1.01 Million - $2.9 Million	-137,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $499,851 - $1.04 Million	137,700 New	137,700 $1.04 Million

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $437M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.